BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26322414)

  • 1. Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.
    Delaney C; Wright RH; Tang JR; Woods C; Villegas L; Sherlock L; Savani RC; Abman SH; Nozik-Grayck E
    Pediatr Res; 2015 Dec; 78(6):634-40. PubMed ID: 26322414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin 2A receptor inhibition protects against the development of pulmonary hypertension and pulmonary vascular remodeling in neonatal mice.
    Delaney C; Sherlock L; Fisher S; Maltzahn J; Wright C; Nozik-Grayck E
    Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L871-L881. PubMed ID: 29345193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled nitric oxide improves lung structure and pulmonary hypertension in a model of bleomycin-induced bronchopulmonary dysplasia in neonatal rats.
    Tourneux P; Markham N; Seedorf G; Balasubramaniam V; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2009 Dec; 297(6):L1103-11. PubMed ID: 19837849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
    Reynolds CL; Zhang S; Shrestha AK; Barrios R; Shivanna B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1597-605. PubMed ID: 27478373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redistribution of Extracellular Superoxide Dismutase Causes Neonatal Pulmonary Vascular Remodeling and PH but Protects Against Experimental Bronchopulmonary Dysplasia.
    Sherlock LG; Trumpie A; Hernandez-Lagunas L; McKenna S; Fisher S; Bowler R; Wright CJ; Delaney C; Nozik-Grayck E
    Antioxidants (Basel); 2018 Mar; 7(3):. PubMed ID: 29538340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Cyclophilin A, Especially Acetylated, Causes Pulmonary Hypertension by Stimulating Endothelial Apoptosis, Redox Stress, and Inflammation.
    Xue C; Sowden M; Berk BC
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1138-1146. PubMed ID: 28450293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered vasoreactivity in neonatal rats with pulmonary hypertension associated with bronchopulmonary dysplasia: Implication of both eNOS phosphorylation and calcium signaling.
    Dumas de la Roque E; Smeralda G; Quignard JF; Freund-Michel V; Courtois A; Marthan R; Muller B; Guibert C; Dubois M
    PLoS One; 2017; 12(2):e0173044. PubMed ID: 28235094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective depletion of vascular EC-SOD augments chronic hypoxic pulmonary hypertension.
    Nozik-Grayck E; Woods C; Taylor JM; Benninger RK; Johnson RD; Villegas LR; Stenmark KR; Harrison DG; Majka SM; Irwin D; Farrow KN
    Am J Physiol Lung Cell Mol Physiol; 2014 Dec; 307(11):L868-76. PubMed ID: 25326578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep.
    Rozance PJ; Seedorf GJ; Brown A; Roe G; O'Meara MC; Gien J; Tang JR; Abman SH
    Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L860-71. PubMed ID: 21873446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of the calcium-binding protein, S100A1, confers pulmonary hypertension in mice associated with endothelial dysfunction and apoptosis.
    Teichert-Kuliszewska K; Tsoporis JN; Desjardins JF; Yin J; Wang L; Kuebler WM; Parker TG
    Cardiovasc Res; 2015 Jan; 105(1):8-19. PubMed ID: 25395393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary hypertension in adult Alk1 heterozygous mice due to oxidative stress.
    Jerkic M; Kabir MG; Davies A; Yu LX; McIntyre BA; Husain NW; Enomoto M; Sotov V; Husain M; Henkelman M; Belik J; Letarte M
    Cardiovasc Res; 2011 Dec; 92(3):375-84. PubMed ID: 21859819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calorie Restriction Attenuates Monocrotaline-induced Pulmonary Arterial Hypertension in Rats.
    Ding M; Lei J; Qu Y; Zhang H; Xin W; Ma F; Liu S; Li Z; Jin F; Fu E
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):562-70. PubMed ID: 25636073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant cGMP signaling persists during recovery in mice with oxygen-induced pulmonary hypertension.
    Perez M; Lee KJ; Cardona HJ; Taylor JM; Robbins ME; Waypa GB; Berkelhamer SK; Farrow KN
    PLoS One; 2017; 12(8):e0180957. PubMed ID: 28792962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin-deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension.
    Roberts DS; Sherlock LG; Posey JN; Archambault JL; Nozik ES; Delaney CA
    Physiol Rep; 2022 Oct; 10(19):e15482. PubMed ID: 36200294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats.
    Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y
    Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic hypercapnia prevents bleomycin-induced pulmonary hypertension in neonatal rats by limiting macrophage-derived tumor necrosis factor-α.
    Sewing AC; Kantores C; Ivanovska J; Lee AH; Masood A; Jain A; McNamara PJ; Tanswell AK; Jankov RP
    Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L75-87. PubMed ID: 22582114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal growth restriction augments oxygen-induced pulmonary hypertension in a neonatal rat model of bronchopulmonary dysplasia.
    Wedgwood S; Warford C; Agvateesiri SC; Thai P; Berkelhamer SK; Perez M; Underwood MA; Steinhorn RH
    Pediatr Res; 2016 Dec; 80(6):894-902. PubMed ID: 27509009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.
    Shatat MA; Tian H; Zhang R; Tandon G; Hale A; Fritz JS; Zhou G; Martínez-González J; Rodríguez C; Champion HC; Jain MK; Hamik A
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):647-53. PubMed ID: 24156273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.